Study of Nilotinib in Metastatic Melanoma With KIT Aberrations
Clinical trial NCT01099514 · COMPLETED
Trial details
- NCT number
- NCT01099514
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2013-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.